Loading...
PED is not a good buy right now. The pre-market move (~0.643, +2.06%) is pushing directly into near-term resistance (R1 ~0.642) with an overbought short-term RSI and no proprietary buy signals today. With weak latest-quarter fundamentals (Q3 2025 revenue/margin declines and losses) and pattern-based odds skewing to further downside over the next week/month, the risk/reward for an impatient entry is unfavorable at this level.
Trend/Setup: Short-term momentum has improved (MACD histogram +0.00958 and expanding), but the stock is extended short-term with RSI_6 at 76.56 (overbought/too hot for a chase). Moving averages are converging, consistent with a choppy/transition phase rather than a clean uptrend. Key Levels: Pivot 0.593. Support S1 0.545 (then S2 0.515). Resistance R1 0.642 (being tested pre-market) and R2 0.672. With price ~0.643, the stock is at/just above R1—often where early buyers take profits. Pattern/Probability: Similar-pattern analysis suggests a 40% chance of -1.25% next day, -4.46% next week, -6.12% next month, reinforcing that upside follow-through from here is not the base case.
Intellectia Proprietary Trading Signals
while RSI_6 is overbought, increasing odds of a pullback rather than a clean breakout.
Latest reported quarter: 2025/Q3.
Recent trend: Only one recent datapoint—on 2025-11-17 Roth Capital reinstated coverage at Buy with an $0.85 price target. Wall Street pro view: